ARWR
#966
Arrowhead Pharmaceuticals, Inc. - Common Stock
60.6 9 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.28%
Changement Mensuel
-26.62%
Evolution sur 6 mois
-6.77%
Changement Annuel
+55.22%
Clôture Précédente
62.7 5
Open
62.4 9
Low
60.5 2
High
62.4 9
Financials
- Market Capitalization 8.57 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3 449
ratio cours/chiffre d'affaires
5.56
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 959 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 166.56 USD | -1.06% | -6.41% | -24.95% | +27.93% | 8.72 B USD | ||
| 965 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.87 USD | -0.06% | -0.43% | -14.47% | +8.21% | 8.74 B USD | ||
| 982 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.04 USD | -0.60% | +1.51% | +1.98% | +63.47% | 8.42 B USD | ||
| 1044 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 86.23 USD | +0.63% | -6.53% | -4.82% | +260.64% | 7.60 B USD |